Trephine
AboutSpecialtiesPricingLoading...

Copyright © 2024 Trephine. All rights reserved. The content of this site is intended for health care professionals.

TREPHINE

Terms Of UsePrivacy Policy

CirculationLetter

06 May 2025

MYSTERY-HF: Myeloperoxidase Inhibition in Patients With Heart Failure and Reduced Ejection Fraction: A Phase II Randomized Controlled Trial.

No abstract available

COI Statement

S. Braumann received nonfinancial support from AstraZeneca and travel grants from Lilly. S.M.-M. received travel grants from Bayer Vital AG outside the submitted work and unrelated to the contents of this article. B.H. received speaker fees from Bristol Myers Squibb, Boehringer Ingelheim, and Pfizer, none of which related to the content of this article. V.t.C. received consulting fees from Bayer AG outside the submitted work and unrelated to the contents of this article. E.M., K.N., and M.A. are employees of and might own shares in AstraZeneca. N.F. reports lecture and consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, and Pfizer Inc, none of which related to the content of this article. M.B. reports personal fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Servier, and Vifor during the conduct of the study. S.F. has received consultancy and lecture fees as well as support/travel grants for meetings from Abbott, Abiomed, Amarin, Amgen, AstraZeneca, Bayer, Berlin-Chemie, Biotronik, Boehringer, Bristol Myers Squibb, Boehringer, Daiichi Sankyo, Edwards, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Siemens, Vifor, and Zoll. P.S.W. reports outside the submitted work grants from Bayer AG, nonfinancial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting, and lecturing fees from Bayer Health Care, grants and consulting fees from Daiichi Sankyo Europe, lecturing fees from Pfizer Pharma, lecturing fees from Bristol Myers Squibb, consulting fees from AstraZeneca, consulting fees and nonfinancial support from Diasorin, and nonfinancial support from IEM. S. Baldus received lecture and speaker fees from Abbot, Edwards, and AstraZeneca. The other authors report no conflicts.

Article info

Journal issue:

  • Volume: 151
  • Issue: 18

Doi:

10.1161/CIRCULATIONAHA.125.074085

More resources:

Atypon

Full Text Sources

Paid

NCI CPTC Antibody Characterization Program

Research Materials

Free resource

NCI CPTAC Assay Portal

Miscellaneous

Free resource

Share: